A project from the American Society of Retina SpecialistsSign in to view content
Baseline Characteristics of Patients Maintaining q12 and q16 Dosing With Aflibercept 8 mg vs Patients With Shortened Treatment Intervals Phase 3 PULSAR Post Hoc Analysis
- Video
- Published 2023
Related
Category: AMD-Neovascular